Stay updated with breaking news from Sung Lee. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.
Aguachile mixed with naengmyeon, an esquites and corn cheese mashup, kimchi micheladas, and fine dining takes on Korean classics fill menus that incorporate influences from New York, LA, and South Korea.
– Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for the Study of the Liver Congress 2024 – – Two additional hepatitis program data readouts...
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/a9/0d/a90d4a77-8b61-41ec-8995-a3e6e619429c/1_-_f1073ecc-da15-4eb1-aea2-96c804d2f639.jpg)
Gather together and commemorate the holiday of gratitude
BeiGene, a global, science-driven biotechnology company, announced the opening of a new site for global developing & manufacturing of small molecule innovative medicines in Suzhou, East China’s Jiangsu Province on November 16. In an exclusive interview, SVP and Global Head of Technical Operations and Manufacturing of BeiGene Dr. Kyu-Sung Lee shared with Global Times his personal stories and elaborated his passion about benefiting patients around the world with innovative medicines, with BeiGene expanding its global manufacturing footprint starting in China.